← Back to Search

Behavioural Intervention

WBV Intervention for Parkinson's Disease

N/A
Recruiting
Research Sponsored by Baylor University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes
Awards & highlights

Study Summary

This trial is looking at how whole body vibration affects how fast people with Parkinson's disease can walk backwards.

Who is the study for?
This trial is for people aged 40-85 with Parkinson's Disease who can walk on their own for at least 5 minutes and are aware of their surroundings. They should be in the early to moderate stages (I - IV) of the disease. Those with recent orthopedic injuries, surgeries affecting gait, or changes in Deep-Brain Stimulation treatments within the last two years cannot participate.Check my eligibility
What is being tested?
The study explores how whole body vibration (WBV) affects backward walking speed in individuals with Parkinson's Disease compared to a control group without this intervention. Participants will be randomly assigned to either receive WBV or not.See study design
What are the potential side effects?
While specific side effects are not detailed, whole body vibration may potentially cause discomfort, fatigue, dizziness, or exacerbate existing musculoskeletal issues during or after treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
3-meter backward walk test (3MBWT)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: WBV InterventionExperimental Treatment1 Intervention
Participants will complete testing on the 3 meter backward test (3MBWT) for 3 trials (pretest). Participants will perform mid-squats on a whole body vibration (WBV) platform. The participant will complete the WBV with the platform next to a wall so they can use the wall for balance if needed. Additionally, supervision or hand held assist will be provided if needed for balance by a licensed physical therapist. After the completion of the WBV session, the participant will complete testing 3MBWT for 3 trials (posttest). All participants will have a gait belt donned the entire time and be closely guarded during every test by a licensed physical therapist. At any point the participant appears unsafe to continue, the protocol will stop immediately. Participants will be given the option to stop and rest when needed.
Group II: Control groupActive Control1 Intervention
Participants will complete testing on the 3 meter backward test (3MBWT) for 3 trials (pretest). Participants will perform 5 sets of 60 seconds of mid-squats on level ground. There will be a 1 minute rest in between each set. The participant will complete the mid-squats next to a wall so they can use the wall for balance if needed. Additionally, supervision or hand held assist will be provided if needed for balance by a licensed physical therapist. After the completion of the the mid-squats, the participant will complete testing 3MBWT for 3 trials (posttest). All participants will have a gait belt donned the entire time and be closely guarded during every test by a licensed physical therapist. At any point the participant appears unsafe to continue, the protocol will stop immediately. Participants will be given the option to stop and rest when needed.

Find a Location

Who is running the clinical trial?

Baylor UniversityLead Sponsor
56 Previous Clinical Trials
65,154 Total Patients Enrolled
University of St. Augustine for Health SciencesOTHER
6 Previous Clinical Trials
410 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals older than two decades eligible for enrollment in this research?

"Patients must be between 40 and 85 years of age to be considered for enrollment in this study based on the eligibility criteria."

Answered by AI

Is the enrollment of participants still ongoing for this clinical trial?

"The current status on clinicaltrials.gov shows that this research endeavor is actively in search of suitable candidates. This investigation was first made public on September 1st, 2022 and the latest update occurred on April 3rd, 2024."

Answered by AI

What is the current number of subjects participating in this medical research study?

"Affirmative. Information from clinicaltrials.gov indicates that this investigation is actively seeking participants. The study was initially published on September 1, 2022 and most recently revised on April 3, 2024. A total of 40 individuals are sought after across a solitary site for enrollment in the study."

Answered by AI

Which individuals meet the eligibility criteria for participation in this medical research study?

"Individuals aged between 40 and 85 years with a diagnosis of Parkinson's disease are eligible for participation in this study, which aims to recruit approximately 40 subjects."

Answered by AI
~14 spots leftby Apr 2025